HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lung transplantation and repair of complex congenital heart lesions in patients with pulmonary hypertension.

Abstract
Pulmonary vascular disease in conjunction with either a previously repaired or an unrepaired congenital heart defect is the third most common indication for lung transplantation in the pediatric age range. Because scarcity of donor organs remains a critical issue and heart-lung donor blocks are becoming diminishingly available, efforts must be directed towards other options such as combining lung transplantation with correction of the underlying congenital heart defect. Certain defects like congenital pulmonary vein stenosis are eradicated by removal of the diseased lungs, whereas others such as complete atrioventricular canal and pulmonary atresia with ventricular septal defect require cardioplegic arrest of the heart and intracardiac repair in conjunction with the lung transplantation. A breakdown of this patient population into subgroups may be helpful both in thinking about the pathophysiology and in determining appropriate indications and timing of transplantation. Earlier studies from our center showed the high-risk nature and formidable undertaking of caring for this complex group of patients. Through continued experience, there has been gradual improvement in early outcomes. As with all other groups of lung transplantation patients, obliterative bronchiolitis remains the major deterrent to long-term survival.
AuthorsE N Mendeloff, C B Huddleston
JournalSeminars in thoracic and cardiovascular surgery (Semin Thorac Cardiovasc Surg) Vol. 10 Issue 2 Pg. 144-51 (Apr 1998) ISSN: 1043-0679 [Print] United States
PMID9620463 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Cardiac Surgical Procedures (methods, mortality)
  • Child
  • Child, Preschool
  • Follow-Up Studies
  • Heart Defects, Congenital (complications, mortality, surgery)
  • Humans
  • Hypertension, Pulmonary (complications, mortality, surgery)
  • Infant
  • Lung Transplantation (mortality)
  • Patient Selection
  • Risk Factors
  • Survival Rate
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: